Randomized Phase II Trial Induction Therapy for Early Stage Breast Cancer
Status:
Completed
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out if the combination of docetaxel and capecitabine can
shrink the size of breast tumors and preserve the breast.
Phase:
Phase 2
Details
Lead Sponsor:
Emory University
Collaborators:
Georgia Center for Oncology Research & Education Sanofi